These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7933723)

  • 1. A theoretical and neurophysiological consideration on the pathogenesis of positive symptoms of schizophrenia: implications of dopaminergic function in the emotional circuit.
    Maeda H
    Jpn J Psychiatry Neurol; 1994 Mar; 48(1):99-110. PubMed ID: 7933723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of schizophrenic delusions and hallucinations: a neural model.
    Ruppin E; Reggia JA; Horn D
    Schizophr Bull; 1996; 22(1):105-23. PubMed ID: 8685653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensory gating deficits, pattern completion, and disturbed fronto-limbic balance, a model for description of hallucinations and delusions in schizophrenia.
    Javanbakht A
    Med Hypotheses; 2006; 67(5):1173-84. PubMed ID: 16824690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hallucinations, consciousness and psychosis].
    Del Cul A; Gaillard R; Jardri R; Fossati P
    Encephale; 2010 Sep; 36(4):348-54. PubMed ID: 20850607
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia.
    Stahl SM
    CNS Spectr; 2007 Apr; 12(4):265-8. PubMed ID: 17426663
    [No Abstract]   [Full Text] [Related]  

  • 7. The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction.
    Laviolette SR; Grace AA
    Cell Mol Life Sci; 2006 Jul; 63(14):1597-613. PubMed ID: 16699809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia.
    Pickar D; Litman RE; Konicki PE; Wolkowitz OM; Breier A
    Mod Probl Pharmacopsychiatry; 1990; 24():124-51. PubMed ID: 1970851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical microcircuits in schizophrenia--the dopamine hypothesis revisited.
    Winterer G
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S68-71. PubMed ID: 16508900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and anatomical aspects of prefrontal pathology in schizophrenia.
    Goldman-Rakic PS; Selemon LD
    Schizophr Bull; 1997; 23(3):437-58. PubMed ID: 9327508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do we still believe in the dopamine hypothesis? New data bring new evidence.
    Abi-Dargham A
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S1-5. PubMed ID: 14972078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine hypothesis of schizophrenia revisited.
    van Kammen DP
    Psychoneuroendocrinology; 1979 Jan; 4(1):37-46. PubMed ID: 39306
    [No Abstract]   [Full Text] [Related]  

  • 13. The interface between dopamine neurons and the amygdala: implications for schizophrenia.
    Haber SN; Fudge JL
    Schizophr Bull; 1997; 23(3):471-82. PubMed ID: 9327510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
    Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
    JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia?
    Laviolette SR
    Schizophr Bull; 2007 Jul; 33(4):971-81. PubMed ID: 17519393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems in recognizing the self: a neuropsychological approach to the positive symptoms of schizophrenia].
    Jeannerod M
    Med Sci (Paris); 2003 May; 19(5):621-4. PubMed ID: 12836397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for reduced and dysregulated turnover of dopamine in schizophrenia.
    Heritch AJ
    Schizophr Bull; 1990; 16(4):605-15. PubMed ID: 2077638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia.
    Benes FM
    J Psychiatr Res; 1997; 31(2):257-75. PubMed ID: 9278189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurochemical circuitry of schizophrenia.
    Carlsson A
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S10-4. PubMed ID: 16508890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia: a subcortical neurotransmitter imbalance syndrome?
    Carlsson M; Carlsson A
    Schizophr Bull; 1990; 16(3):425-32. PubMed ID: 1981107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.